Related Experiment Videos

Dissociation between tumour resistance and delayed-type hypersensitivity to tumour-associated antigens in the mouse

Immunology
|January 1, 1980
PubMed

Insights

Tumor resistance in mice was transferable via spleen cells, not serum. Delayed hypersensitivity, transferable by both cells and serum, showed no correlation with tumor resistance.

Area of Science:

  • Immunology
  • Oncology
  • Tumor immunology

Background:

  • Investigating the relationship between host immune responses and tumor growth is crucial for developing effective cancer therapies.
  • Methylcholanthrene-induced fibrosarcoma (Meth A) in mice provides a model to study tumor-specific immunity.

Purpose of the Study:

  • To compare tumor resistance with delayed-type hypersensitivity in a syngeneic mouse model.
  • To elucidate the mechanisms underlying tumor resistance and delayed-type hypersensitivity.

Main Methods:

  • Induction of tumor resistance in mice using Meth A fibrosarcoma cells.
  • Transfer experiments using spleen cells and serum to assess immune mediators.
  • Assessment of delayed-type hypersensitivity via skin reactivity tests.

Main Results:

  • A single injection of Meth A cells induced resistance to tumor growth in 90% of mice.
  • Tumor resistance was transferable by spleen cells but not by serum.
  • Delayed skin reactivity was observed in both tumor-resistant and tumor-bearing mice and was transferable by spleen cells and serum.

Conclusions:

  • A dissociation exists between tumor resistance and specific delayed-type hypersensitivity.
  • Delayed skin reactivity in this model appears to be mediated by humoral antibodies, not cell-mediated immunity.
  • Host resistance to tumor growth is cell-mediated and not transferable by serum, explaining the lack of correlation with delayed hypersensitivity.

Related Concept Videos